The impressive blog 4331

If you sit in enough exam rooms and operating theaters, the word “regeneration” stops sounding futuristic and starts feeling very practical. To a working clinician, it means one simple thing: can we help the body rebuild itself rather than just patching it? That simple idea has grown into an entire field: regenerative medicine. It ranges from bone marrow transplants that cure blood cancers to platelet injections for arthritic knees, to gene therapies that restore missing functions in rare diseases. Yet patients often arrive with very reasonable questions: What is a regenerative medicine doctor, are these treatments painful, do they work, and who actually pays for all of this? This article walks through how doctors think about regeneration, the four main types used in modern practice, and the hard realities around cost, success rates, and risk. What doctors mean by “regeneration” In basic biology, textbooks describe four types of regeneration in animals: epimorphic, morphallactic, compensatory, and super-regeneration. That framework helps explain how a salamander can grow a new limb, but it is not how clinicians organize treatment decisions. In modern medicine, when physicians talk about “types of regeneration,” we usually group therapies based on how they stimulate repair: Cellular regeneration Biochemical or signaling-based regeneration Structural or tissue-engineering regeneration Genetic or reprogramming-based regeneration Each type has its own tools, regulatory status, evidence base, and real-world limitations. Before we go there, it helps to clarify who is actually doing this work. What is a regenerative medicine doctor? There is no single residency called “regenerative medicine.” Instead, regenerative medicine doctors are usually specialists who have added training in biologic or cell-based treatments. In my experience, you most often see: Orthopedic surgeons and sports medicine physicians doing platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and related joint injections. Physical medicine and rehabilitation (PM&R) physicians running non-surgical spine and joint clinics that offer biologics along with therapy and injections. Hematologists and oncologists managing bone marrow and stem cell transplants. Dermatologists, plastic surgeons, and wound-care physicians using engineered skin, growth factors, and grafts for complex wounds and burns. Ophthalmologists using regenerative approaches for corneal diseases and retinal conditions. Academic centers sometimes have “regenerative medicine” institutes that combine many of these specialties under one umbrella. The common thread is using cells, genes, or engineered tissues to restore structure and function. How much do regenerative medicine doctors make? Income depends far more on the underlying specialty and practice model than on the word “regenerative” in a job title. In the United States: Orthopedic surgeons, especially those who do sports medicine or spine plus regenerative work, often earn in the 500,000 to 800,000 dollar range, sometimes more with private practice ownership. PM&R and sports medicine physicians in non-surgical roles commonly fall around 250,000 to 450,000 dollars. Hematologists/oncologists involved in transplant programs may earn roughly 300,000 to 600,000 dollars, varying widely by region and practice. Regenerative cash-pay procedures (for example, non-covered stem cell injections) can increase revenue for a practice, but they also carry higher ethical and regulatory scrutiny. Patients sometimes ask which is the highest paid doctor specialty overall. In recent compensation surveys, neurosurgery, thoracic surgery, and orthopedic surgery usually lead the list. On the other end, the lowest paying doctor specialty categories tend to be primary care fields like pediatrics and family medicine, despite their central importance to the health system. The four practical types of regeneration in current medicine 1. Cellular regeneration: stem cells and cell-based therapies When most people hear “regenerative medicine,” they picture stem cells. This is the classic cellular regeneration model: place the right cells in the right environment so they can rebuild tissue or modulate inflammation. The most established example is hematopoietic stem cell transplantation, often called a bone marrow transplant. We use it to reset or replace diseased bone marrow in conditions like leukemia, lymphoma, and certain immune disorders. This is not experimental. It is mainstream oncology and has decades of data Regenerative Medicine Doctor Scottsdale behind it. Orthopedic and sports applications are far younger and more variable. Common approaches include: Bone marrow aspirate concentrate (BMAC) from the pelvis, injected into joints or tendons. Adipose-derived cell preparations from liposuctioned fat, processed and injected. Culture-expanded mesenchymal stem cells, which are tightly regulated in the United States but offered more freely in some other countries. A much-discussed example is Joe Rogan’s stem cell treatment. He has publicly described traveling to Panama to receive high-dose intravenous and intramuscular umbilical cord-derived stem cell infusions, reportedly at the Stem Cell Institute in Panama City. That sort of treatment is not FDA-approved in the United States for the indications he mentions, which is why people fly to centers in Panama, Mexico, or other countries. When patients ask what country is best for stem cell treatment, the honest answer is that there is no single “best” country. There are: Countries with stricter regulation and more data-driven programs (for example, the United States, parts of Europe, Japan) where many regenerative therapies are limited to clinical trials or specific indications. Countries with more permissive regulations, where clinics can offer broad “stem cell” treatments for many conditions without strong evidence. Patients may experience benefit, but the data are far less robust, and the risks are harder to quantify. From a safety and science standpoint, I encourage patients to prioritize: Clear regulatory oversight. Published data for the specific condition being treated. Transparent complication reporting. The convenience of flying somewhere for a one-week miracle cure is emotionally appealing, but biology rarely cooperates with that fantasy. 2. Biochemical regeneration: growth factors, PRP, and biologic signals Cells are only part of the story. They respond to biochemical signals: growth factors, cytokines, and extracellular matrix fragments. Many practical regenerative treatments focus on improving the signaling environment, even without adding new cells. Platelet-rich plasma (PRP) is the workhorse here. The physician draws a patient’s blood, spins it in a centrifuge, and injects a concentrated platelet layer into a joint, tendon, or skin. Platelets release growth factors that can reduce inflammation and support tissue repair. In orthopedics, PRP is fairly well studied for conditions like tennis elbow and mild to moderate knee osteoarthritis. Results are mixed but often better than saline or steroid in the medium term, especially when targeted appropriately and combined with rehabilitation. Other examples of biochemical or signaling-based regenerative treatments include: Concentrated growth factor preparations for chronic wounds. Amniotic membrane-derived products used in eye disease and some orthopedic indications. Biologic drugs that stimulate or block specific tissue pathways, such as bone-stimulating agents in osteoporosis. These treatments blur the line between classical pharmacology and regeneration, but in practice, many clinicians consider them part of the regenerative toolkit because they support the body’s repair cascades rather than simply masking symptoms. 3. Structural regeneration: scaffolds, grafts, and tissue engineering Sometimes the body needs a framework to grow into. Structural or tissue-engineering approaches provide physical scaffolds, often loaded with cells or growth factors, to guide regeneration. In the operating room, you see this in: Engineered skin substitutes for burns and chronic wounds. Collagen or synthetic scaffolds for cartilage repair in the knee. Bone grafts combined with growth factors to promote spinal fusions. Biodegradable meshes and matrices used in hernia repair and reconstructive surgery. Research labs push this further with 3D bioprinting of tissues like cartilage, early-stage liver models, and vascularized constructs. Most of those are not at the bedside yet, but they inform the devices and grafts we do use. Clinically, structural regeneration often pairs with the other three types. A scaffold might be seeded with stem cells (cellular), infused with growth factors (biochemical), or used in a patient whose cells have been genetically modified (genetic). 4. Genetic and reprogramming-based regeneration The newest and most complex pillar involves changing the genetic instructions so that cells behave in regenerative ways. Gene therapy inserts or corrects genes to restore functions that were missing or defective. For example: Certain forms of inherited retinal disease are now treated with gene therapy that can partially restore vision. Gene therapies for spinal muscular atrophy and some immunodeficiencies have transformed previously lethal childhood diseases into manageable conditions. In a regenerative context, gene-based therapies aim either to: Enable cells to produce missing structural proteins. Change how cells respond to injury and inflammation. Reprogram one type of cell into another, more regenerative type. Laboratories use tools like CRISPR and induced pluripotent stem cells (iPSCs) to experiment with turning adult cells back into a stem-like state and then forward into new tissues. Clinical applications are still early, but the concept is simple: instead of adding cells from outside, you reprogram cells in place or in a dish so they can rebuild tissue more effectively. Is regenerative medicine painful? Most regenerative procedures live in the same pain range as other injections or minor surgeries. The experience depends heavily on the specific treatment: PRP injections into joints usually feel like a standard joint injection. Tendon injections can be sharper and more uncomfortable, sometimes requiring local anesthetic or nerve blocks. Bone marrow aspirate harvests from the pelvis can be quite uncomfortable if done with minimal anesthesia, though sedation or regional blocks reduce that significantly. Intravenous stem cell infusions are usually painless apart from IV placement. Surgical regenerative procedures, like cartilage restoration or grafting, carry the same postoperative pain profile as comparable surgeries without regenerative elements. Patients are often less concerned about the needle stick itself and more worried about a “pain flare” after treatment. For example, PRP in an arthritic knee can increase soreness for a few days before improvement begins. Adequate pre-procedure counseling and a clear plan for activity modification matter as much as the injection. Who is a good candidate for regenerative medicine? When I evaluate someone for a regenerative treatment, I am asking three practical questions: Do we understand what is structurally wrong, is there reasonable evidence that a given regenerative approach helps that problem, and is the patient in a position to tolerate the risks, costs, and rehabilitation? Patients who often make good candidates tend to share several features: A clearly defined diagnosis, ideally supported by imaging or objective testing, where the target tissue is known to respond to a specific regenerative method. Failure of appropriate conservative care, such as targeted physical therapy, standard medications, and conventional injections, unless there is a reason to skip straight to more advanced options. Realistic expectations: hoping for reduced pain and improved function, not a guarantee of cure or a reversal of decades of damage. Adequate overall health and metabolic status to heal, including good control of diabetes, no uncontrolled infections, and at least moderately healthy nutrition and lifestyle habits. Financial clarity: understanding the cost, the likelihood that insurance will not pay for the regenerative portion, and the fact that multiple sessions may be recommended. Age alone is not a strict barrier. I have seen older adults respond beautifully to well-chosen biologic injections and younger patients fail because the diagnosis was wrong or the expectations were unrealistic. Costs, insurance, and branded programs like Kinetix The financial side of regeneration is one of the biggest sources of confusion and frustration. Will insurance pay for regenerative medicine? Some regenerative therapies are fully integrated into standard care and covered by insurance: Bone marrow and stem cell transplants for approved cancer and blood indications. Certain wound-care products and biologic grafts. Specific gene therapies for FDA-approved conditions. Where patients run into trouble is with elective orthobiologic treatments for musculoskeletal problems. In most of the United States: PRP injections are usually not covered and are paid out of pocket. Clinic-based stem cell injections derived from your own bone marrow or fat are also typically not covered. Registry or clinical trial participation may offset costs in academic settings, but that is not the norm in private practice. So will insurance pay for regenerative medicine? Sometimes, but not for many of the knee, shoulder, spine, and general “anti-aging” uses advertised online. Patients need to ask very specifically: is this particular code, for this particular injection or graft, covered for my diagnosis? What is the average cost of regenerative medicine? Costs vary widely by region, clinic, and procedure. In many U.S. Markets, you see ranges like: PRP: roughly 500 to 2,500 dollars per treatment, depending on the system used and the number of sites injected. Bone marrow or adipose-derived cell procedures (non-surgical): about 3,000 to 10,000 dollars per area, sometimes more. Complex multi-day “stem cell programs” abroad: 8,000 to 25,000 dollars or more, plus travel and lodging. Routine insurance-covered regenerative elements, such as grafts used during surgery, are typically buried within the surgical billing and look like any other hospital charge from a patient’s perspective. Regarding specific branded programs, many patients ask, does insurance cover Kinetix. Kinetix is a trade name used by some clinics and systems for regenerative or biologic programs, often focused on joint preservation or soft-tissue repair. In my experience, traditional insurers rarely cover the proprietary regenerative components of these programs if they involve PRP or similar biologics. They may cover associated imaging, physical therapy, and standard visits, but the actual biologic injection or kit is usually a cash-pay item. Before committing, it is reasonable to ask the clinic for a written estimate that separates: Professional fees for the visit or procedure. Facility fees, if any. Specific biologic or device costs that are not billed to insurance. What is the success rate of regenerative medicine? Patients often want a single number, but the reality is very condition-specific. For example: Certain bone marrow transplants for leukemia have long-term disease-free survival rates that justify the significant short-term risk. That is one end of the spectrum. PRP for early knee osteoarthritis may show meaningful improvement in pain and function in roughly half to two-thirds of appropriately selected patients in published studies, but effect sizes vary and are often modest. Adipose or bone marrow-derived “stem cell” injections for advanced osteoarthritis have much thinner evidence; some small series report improvement, others see little difference compared with placebo or standard care. When someone asks, what is the success rate of regenerative medicine, an honest answer is: it depends heavily on what you are treating, which specific technique is used, and how success is defined. A 30 to 50 percent reduction in pain and better function is a success for many chronic joint patients, even if their MRI still shows arthritis. Good clinics will: Quote data for your specific condition, not “stem cells help everything.” Use validated outcome measures, not just testimonials. Acknowledge that a meaningful subset of patients will not respond even in ideal circumstances. The biggest problems and disadvantages of regenerative medicine From a clinician’s standpoint, the promise of regenerative medicine is real, but so are its problems. Several disadvantages come up repeatedly in practice: Evidence gaps and variability For some indications, like bone marrow transplant, data are robust. For many orthobiologic uses, studies are small, protocols differ, and long-term outcomes are unclear. Patients often get swept up by marketing before the science is settled. Cost and access Cash-pay regenerative procedures can be financially devastating, especially when patients pursue multiple rounds hoping to “finally” get better. Insurance structures favor drugs and surgeries with clear codes, not emerging biologics without consensus billing pathways. Regulatory gray zones Some clinics operate in legally murky territory, stretching definitions of “minimal manipulation” or claiming to be “research” without rigorous oversight. This makes it difficult for patients to distinguish serious programs from opportunistic ones. Unrealistic expectations When people hear that a stem cell “regenerates,” they picture a worn-out joint turning into a teenager’s knee. The disappointment, and the pressure on physicians, can be intense when the outcome is more subtle: less pain, slightly better function, but no miracle. Safety and unknown long-term effects Immediate complications like infection, bleeding, or nerve injury are similar to other injection-based care, but the long-term effects of certain cell manipulations or repeat biologic exposures remain under study. The largest overarching problem with regenerative medicine today is the mismatch between hype and data. The science is promising and steadily maturing. The marketing has often leaped far ahead, especially in cash-based musculoskeletal clinics and medical tourism packages. Does fasting for 72 hours regenerate cells? Extended fasting has become another popular topic in conversations about regeneration. A frequently cited line of research from mouse studies suggests that prolonged fasting cycles can trigger stem-cell based renewal in the immune system. Media headlines turned this into “fasting for 72 hours regenerates cells.” Here is the more careful context: In mice, extended fasting periods led to changes in hematopoietic stem cells and immune cell populations, with signs of improved resilience when feeding resumed. Early human data hint that prolonged fasting or fasting-mimicking diets may shift immune and metabolic markers in favorable ways. However: These are not substitutes for medical regenerative procedures. The magnitude and durability of human “regeneration” from fasting are uncertain. A 72-hour fast is not safe for everyone: people with diabetes on medications, those with eating disorders, pregnant women, frail older adults, and others face real risks. For generally healthy individuals, intermittent fasting or occasional supervised fasting-mimicking diets might support metabolic and cellular health, but the phrase “regenerate cells” is oversimplified. It is better to say that certain fasting protocols may nudge the body toward a more youthful pattern of repair and turnover, but they are not comparable to targeted regenerative therapies for specific injuries or diseases. Practical advice for patients considering regenerative therapies Regenerative Medicine Doctor Scottsdale If you are weighing a regenerative option, a few practical steps can protect you from disappointment and unnecessary risk. First, clarify the diagnosis in conventional terms. Before asking what type of regeneration is best, make sure you know which structure is damaged and why. Get a second opinion on the basics if needed. Second, ask your doctor where the proposed treatment sits on the spectrum from well-established to experimental. A bone marrow transplant for leukemia is not the same as a stem cell injection into a spine for vague back pain. Third, insist on specifics about cost and coverage. “We’ll submit it to your insurance and see” usually translates into a surprise bill later. Ask explicitly whether the regenerative component is considered experimental, and ask for cash estimates in writing. Fourth, pay attention to how the clinic talks about success. If everything “regenerates” and almost everyone supposedly does great, that is not how real-world medicine looks. Look for nuance: who tends to respond, who does not, what happens if you are in the non-responder group. Finally, remember that regenerative medicine is not magic. It works best when it amplifies a foundation of good sleep, reasonable nutrition, thoughtful movement, and appropriate conventional care. Even the most sophisticated cell therapy cannot compensate for an untreated systemic disease, chronic smoking, or wildly uncontrolled diabetes. Regeneration, at its best, is the art of helping the body do what it is already trying to do, with a bit more precision and support. When doctors, patients, and payers respect both the potential and the limits of that art, it can be a powerful addition to modern medicine rather than a costly detour. Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

Every few months a new claim cycles through health podcasts and social media: if you fast for 72 hours, your body will “reset,” your immune system will “rebuild,” and you will “regenerate” new cells as if you had a new lease on life. There is a grain of truth buried inside that promise, but it is surrounded by a lot of wishful thinking and marketing language. As a physician who works with metabolic health and regenerative medicine, I see both sides: the genuinely exciting science and the very real risks when people treat early data as settled fact. This article walks through what we actually know about 72 hour fasting, autophagy, stem cells, and “regeneration,” and how that intersects with the broader field of regenerative medicine. I will also address practical questions patients often ask me, including cost, insurance, discomfort, and who is and is not a good candidate. What “cell regeneration” really means The phrase “cell regeneration” gets used loosely. In biology and in clinical practice, it usually means one of three things. First, routine cellular turnover. Your gut lining renews roughly every few days, your skin over several weeks, and your red blood cells every 3 months or so. This is normal physiology, not a special hack. Second, repair after injury. When your liver is damaged by alcohol or toxins, it can regenerate large portions of itself if the injury is not too advanced. Skeletal muscle, bone, and even some heart tissue can remodel after damage, although not perfectly. Third, true regenerative processes. In research laboratories, scientists talk about regeneration at several levels. A simple textbook breakdown of the 4 types of regeneration includes: Epimorphosis, where cells at the injury site de-differentiate and form a blastema that regrows a lost structure, as in salamander limb regrowth. Morphallaxis, where remaining tissue reorganizes to form a smaller but complete organism, as in some hydra species. Compensatory regeneration, where remaining cells divide to restore function without forming a blastema, as seen in mammalian liver regeneration. Cellular regeneration, where specific cell populations, often stem or progenitor cells, repopulate damaged tissue. Humans have limited epimorphic ability compared to animals like salamanders, but we do use compensatory and cellular regeneration constantly. The excitement around fasting comes from its potential to push the body toward more efficient cellular cleanup and renewal, especially through autophagy and stem cell activation. What happens in a 72 hour fast In my practice, I rarely recommend an unsupervised water-only 72 hour fast, especially for first timers. But to understand why people are drawn to it, you need a clear view of the physiology. The human body stores energy first as glycogen in liver and muscle, and second as fat. Short fasts mostly deplete glycogen. By around 24 hours without calories, most people have burned through a substantial portion of liver glycogen and are relying more heavily on fat stores, producing ketones as an alternative fuel. Between roughly 24 and 72 hours, several important shifts occur: Glucose and insulin fall. Lower insulin means less anabolic signaling and more catabolic cleanup. For those with insulin resistance, this period can feel surprisingly stable once they get over the first day. Ketones rise. Beta-hydroxybutyrate, a primary ketone, increases and serves as fuel for the brain and muscles. Many people report better mental clarity and reduced hunger once they are fully in ketosis. Autophagy becomes more active. Autophagy is an intracellular housekeeping process where cells break down damaged proteins and organelles. Nutrient deprivation is one of the stronger triggers. Most of the detailed autophagy data comes from animal and cell models, but indirect markers in humans suggest that fasting and significant caloric restriction increase autophagic activity. Immune cell dynamics shift. This is where the “immune regeneration” headlines come from. In mouse studies, repeated cycles of prolonged fasting have been shown to reduce circulating white blood cells, then stimulate hematopoietic stem cells to generate new ones during refeeding. It is a logical, energy-efficient strategy: during scarcity, the body prunes older or less efficient immune cells, then repopulates when food returns. Hormones adjust. Growth hormone rises significantly in many people during longer fasts, which conserves muscle mass and supports lipolysis. Thyroid hormone conversion can shift, sometimes lowering triiodothyronine (T3) as the body conserves energy. So is the body “regenerating” during a 72 hour fast? Parts of it, in a limited and context-dependent way: more autophagy, some degree of immune cell turnover, and a metabolic environment that tends to favor cleanup over growth. What we do not have is strong human evidence that a single 72 hour fast “resets” your immune system or broadly regenerates organs in a way that would translate into dramatic long term health improvements on its own. Human data: what is known, what is not Most of the eye catching claims about prolonged fasting and regeneration trace back to work by Valter Longo, PhD, and colleagues. In mice, cycles of prolonged fasting led to: Reductions in IGF-1 and other growth signals associated with aging Increased autophagy Enhanced hematopoietic stem cell driven regeneration of white blood cells after refeeding Benefits in models of autoimmunity and chemotherapy toxicity In humans, the data set is smaller and more nuanced: Fasting mimicking diets. Instead of strict water fasting, Longo’s group tested a 5 day very low calorie, low protein “fasting mimicking diet.” In small trials, participants saw reductions in IGF-1, blood pressure, and trunk fat, and favorable changes in certain inflammatory markers. There were hints of immune cell profile shifts, but not the dramatic “wipe and replace” seen in mice. Shorter fasts. Intermittent fasting and time restricted eating have more human data, especially for metabolic benefits: improved insulin sensitivity, weight loss, and possibly better blood pressure and lipids. These protocols rarely reach the 72 hour mark. True 72 hour water fasts. Here, human data is mostly from small experimental studies or observational reports, often with fewer than a few dozen participants. Outcomes like weight loss, ketone production, blood pressure, and subjective well being improve in many people. Markers of autophagy in humans are harder to measure directly, so much of what we infer comes from known physiology and animal data. As a clinician, I interpret the current state like this: a 72 hour fast probably increases autophagy meaningfully and may nudge certain stem cell populations to be more active during refeeding. It is very unlikely to regenerate organs in any dramatic way, and certainly not on the level of what we attempt with regenerative medicine procedures like stem cell injections or tissue engineering. Does fasting for 72 hours regenerate cells? The honest answer is: it depends what you mean by “regenerate,” but for most people the effect is modest, localized, and heavily dependent on what you do afterward. Here is a pragmatic breakdown: Cellular cleanup is very likely. Autophagy and related processes help cells remove damaged proteins, misfolded structures, and old mitochondria. A sustained period of nutrient deprivation is one of the better triggers we know. This cleanup is a key part of healthy cellular renewal. Some stem cell activation is plausible. In animal studies, hematopoietic and intestinal stem cells respond strongly to fasting and refeeding cycles. In humans, we suspect similar patterns, but do not have large scale, robust data. If stem cells are stimulated, the effect will be most evident in fast turnover tissues like blood and gut. Tissue level regeneration is limited. You are not regrowing cartilage or reversing a long standing tendon tear with a weekend fast. Chronic joint or spine damage, for instance, usually requires mechanical unloading, targeted rehab, and sometimes regenerative injections to see structural improvement. The benefit is cumulative. If you pair periodic fasting with resistance training, nutritional adequacy on eating days, sleep, and management of chronic diseases, you are likely to see significantly better function and longevity over time. A single isolated 72 hour fast is more like a metabolic stress test than a magic reset. So yes, fasting for 72 hours probably supports certain regenerative processes at the cellular level, especially cleanup and turnover in rapidly renewing tissues. No, it is not a substitute for comprehensive care, nor is it a guarantee of long term benefits. When a 72 hour fast is a bad idea In clinic, I spend more time talking people out of unsupervised prolonged fasting than talking them into it. The risks are real, especially if you have underlying conditions, take medications, or have a history of disordered eating. Here is a concise list of people who should completely avoid a 72 hour water-only fast unless they are in a formal, medically supervised program: Those with type 1 diabetes or advanced type 2 diabetes on insulin or sulfonylureas Pregnant or breastfeeding individuals Anyone with a history of eating disorders, especially anorexia or bulimia People who are underweight, frail, or have significant unintentional weight loss Patients with advanced heart, kidney, or liver disease There are other gray zones. People on blood pressure medication, those with a history of gout, and those on multiple psychiatric medications need a careful, individualized plan and close monitoring if they fast beyond 24 hours. Electrolyte disturbances, severe hypotension, and mood changes are all possible. If someone is curious about fasting, I usually start with 12 to 16 hour overnight fasts, then progress gradually. Jumping straight to 72 hours is like going from couch to ultra-marathon with no training. Where fasting and regenerative medicine intersect Regenerative medicine is a broad, sometimes overhyped field that aims to repair, replace, or restore damaged cells, tissues, or organs. Patients come in asking: What is a regenerative medicine doctor exactly, and how does that connect to something as simple as not eating for a few days? A regenerative medicine doctor is usually a physician trained in a core specialty such as orthopedics, physical medicine and rehabilitation, sports medicine, internal medicine, or sometimes neurology, who then develops focused expertise in treatments that harness the body’s own repair mechanisms. That can include platelet rich plasma (PRP) injections, autologous stem cell procedures (using your own cells), certain scaffold or matrix implants, and in some cases biologic drugs that influence tissue regeneration. The most effective regenerative programs I have seen combine procedural therapies with systemic strategies. Metabolic health, sleep, resistance training, and nutrition directly affect how well your tissues respond to PRP or stem cell injections. Fasting sits squarely in that systemic bucket. A metabolically flexible person who tolerates light fasting, maintains a healthy weight, and has good glycemic control heals more predictably after a regenerative procedure than someone with uncontrolled diabetes and chronic inflammation. So while fasting is not regenerative medicine in the procedural sense, it can influence the internal environment in which regenerative therapies operate. The biggest problems and disadvantages of regenerative medicine Patients often arrive with sky high expectations, in part because they have heard stories from athletes or celebrities. Joe Rogan, for instance, has spoken frequently about receiving stem cell treatment in Panama, specifically at the Stem Cell Institute in Panama City, for joint and back issues. Clinics like that operate in a relatively permissive regulatory environment, which allows them to use cell types and protocols that are not approved in the United States. This highlights several core problems in the field. To keep it concrete, here are five of the most important disadvantages and challenges in regenerative medicine today: Variable evidence quality. Some uses, like PRP for certain tendon injuries, have decent randomized trial data. Others rely on case series, registry data, or marketing claims with very little rigorous backing. Regulatory gray zones. In the United States, the FDA tightly regulates expanded or culture grown stem cells, but allows some minimally manipulated autologous preparations. Other countries have looser rules, which can attract “stem cell tourism” without strong safety oversight. Cost and access. Many regenerative procedures are expensive and not covered by insurance, putting them out of reach for most patients. Training and standards. “Regenerative medicine” is not a protected term. A weekend course can turn a physician or chiropractor into a self described expert, even if they lack deep training in imaging, anatomy, or orthobiologics. Unrealistic expectations. Marketing often implies near miraculous recovery, which does not align with the incremental gains I typically see in real clinic populations. Beyond those systemic problems, individual patients can experience clear disadvantages: out of pocket costs, travel burden, variable pain during and after procedures, and the emotional toll of hope followed by partial or no improvement. Costs, insurance, and financial realities Money questions come up in almost every consultation. People ask: What is the average cost of regenerative medicine? Will insurance pay for regenerative medicine, or for something specific like Kinetix injections? How much do regenerative medicine doctors make, and does that create conflicts of interest? The financial landscape is complicated and varies widely by country and by procedure, but a few patterns hold in the United States. For musculoskeletal regenerative procedures such as PRP or bone marrow derived cell injections, typical cash prices range from about 500 to 2,000 USD for standard PRP, and 2,000 to 8,000 USD or more for stem cell based procedures involving bone marrow or adipose tissue. Complex multi site treatment plans can exceed those numbers. What is the average cost of regenerative medicine, broadly speaking? If you force a general range, many common orthopedic biologic treatments land somewhere between 1,500 and 6,000 USD per episode of care, depending on complexity and geography. Will insurance pay for regenerative medicine? For most biologic injections, the current answer in the United States is no. Some carriers are beginning to reimburse certain PRP indications, and occasionally adjunctive biologics used during surgery, but the majority of PRP and cell based procedures remain self pay. Patients specifically ask: Does insurance cover Kinetix? Kinetix is a brand associated with certain regenerative or orthobiologic treatments marketed for joint pain. Coverage depends on the exact product, how it is billed, and the insurance plan, but practically speaking, most insurers still categorize these treatments as experimental and deny payment. I always tell patients to assume a cash model unless they see a written preauthorization from their insurer. On the physician side, how much do regenerative medicine doctors make is hard to answer precisely, because very few are coded as such. Income tracks more with the underlying specialty. In most surveys, the highest paid doctor specialty categories include neurosurgery, orthopedic surgery, cardiology, and some interventional fields, often in the 600,000 to 1,000,000 USD per year range at the top end. The lowest paying doctor specialty categories tend to include pediatrics, family medicine, and some primary care oriented fields, often in the 200,000 to 260,000 USD per year range. A regenerative medicine oriented orthopedist who runs a high volume cash-based clinic will sit much closer to the high income side than a primary care physician who occasionally refers for PRP. Financial incentives do matter. When a physician’s income depends heavily on performing expensive, non covered injections, patients have to rely even more on the doctor’s integrity. I encourage people to ask directly about success rates, alternatives, and whether the physician would recommend the same procedure to a close family member. Pain, success rates, and who makes a good candidate Another frequent concern is whether regenerative medicine is painful. Most regenerative injections involve needles, sometimes guided by ultrasound or fluoroscopy. With good local anesthesia, many patients describe the procedures as uncomfortable but tolerable, similar to a dental visit. The post procedure period can be more challenging, especially with PRP or bone marrow derived injections to joints or tendons, because we often provoke inflammation as part of the healing response. Expect soreness that can last days to a couple of weeks, along with temporary activity restrictions. What is the success rate of regenerative medicine? That phrase is almost meaningless without specifying the condition, the treatment, and the definition of success. For example: PRP for chronic tennis elbow has reasonable data suggesting that a majority of patients, often in the 60 to 80 percent range, report meaningful pain reduction and functional improvement compared with steroid injections or placebo, especially over 6 to 12 months. Stem cell like injections for knee osteoarthritis show a more mixed picture. Some trials and case series report significant pain relief and functional gains in perhaps half to two thirds of patients, others show more modest or no benefit compared with hyaluronic acid or physical therapy. Structural regeneration of cartilage visible on MRI is less consistent than symptom relief. Who is a good candidate for regenerative medicine depends on several practical factors: the nature and severity of the injury or degeneration, the patient’s metabolic and overall health status, their willingness to commit to rehabilitation, and their financial situation. A middle aged patient with a focal tendon tear, good metabolic health, and realistic expectations is a far better candidate than someone with end stage bone on bone osteoarthritis who is hoping to avoid an inevitable joint replacement with one injection. Interestingly, fasting and other metabolic interventions can move someone from marginal to better candidate by improving inflammation, insulin resistance, and body weight. I have seen patients who lost 10 to 20 percent of their body weight and improved their sleep and blood sugar achieve Regenerative Medicine Doctor Scottsdale better, more durable results from regenerative procedures. Is there a “best country” for stem cell treatment? Patients sometimes phrase it bluntly: What country is best for stem cell treatment? They have heard about Panama, Mexico, Germany, or clinics in Eastern Europe, often through athletes or podcasts. The reality is uncomfortable. Countries like Panama and Mexico host clinics that use cell preparations, doses, and routes of administration that go beyond what is allowed in the United States. Some are run by capable teams with genuine scientific intent, others are barely regulated businesses. Rigorous outcome data across large numbers of patients is sparse. From a strictly evidence based standpoint, no country can honestly claim to be “best” right now. The United States lags in access but has tighter safety oversight for approved uses. Some European systems have strong academic programs, but patients may not qualify for trials. Countries with more liberal regulations offer access, but at the cost of weaker safety and efficacy data. My advice is to focus less on geography and more on: The specific condition you want treated The type of cells and delivery method proposed The clinic’s data, including complication rates and long term follow up The transparency of their consent process and willingness to discuss alternatives A weekend fast at home will not substitute for any of this, but it is a reminder that powerful biological shifts are still accessible without getting on a plane. How to think about 72 hour fasting in a long term plan Instead of chasing a singular “regenerative” fast, I encourage people to think in terms of cycles and context. A person in their 30s or 40s with no major medical issues who eats a whole food diet, maintains a healthy weight, exercises regularly, and sleeps well will get more from an occasional 24 to 48 hour fast than a metabolically unhealthy person will get from a heroic 72 hour water fast once a year. If you are curious and medically appropriate, it is reasonable to: Start with daily time restricted eating, such as a 12 to 14 hour overnight fast, then gradually explore 16 hours once a week. Monitor how your energy, mood, and blood sugar respond. Work with your physician if you take medications, especially for blood pressure, diabetes, or mood disorders. Once you are comfortable and stable with shorter fasts, a carefully planned 24 hour fast can extend the metabolic benefits, often without major side effects. Continue to prioritize hydration, electrolytes, and good nutrition on eating days. Only after you and your clinician are confident about these shorter fasts should you even consider a 48 to 72 hour fast, and even then, it may not add much beyond what consistent, moderate interventions already achieve. Fasting is a tool, not an identity. Used wisely, it can support the same cellular processes that regenerative medicine aims to harness: better autophagy, healthier mitochondria, and more resilient tissues. Used recklessly, it can aggravate underlying conditions and distract from more important work like strength training, blood sugar control, and addressing sleep apnea. The promise of regeneration is seductive, whether it comes from a clinic overseas or a three day fast at home. The real gains usually arrive quietly, over months and years, built from hundreds of small, repeatable choices rather than a single dramatic intervention.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

Regenerative medicine promises something very powerful: instead of just managing symptoms, try to repair or replace damaged tissues and help the body heal itself. Stem cell injections for arthritic knees, platelet rich plasma for tendons, biologic scaffolds for cartilage, even experimental gene therapies. The marketing sounds almost too good to be true, and that is where the real concerns begin. I work with patients who ask about these treatments almost every week. Some arrive with printouts from clinics abroad. Others heard Joe Rogan talk about his stem cell treatment in Panama and want the same. A few are convinced that a 72 hour fast will regenerate their cells and fix chronic problems. The reality is more complicated, and the disadvantages of regenerative medicine, as it is actually practiced, are substantial. Understanding those drawbacks can help you decide when these therapies might be worth exploring, and when caution or a different approach is wiser. What exactly is a regenerative medicine doctor? Before talking about risks and disadvantages, it helps to be clear on who is actually providing these treatments. A regenerative medicine doctor is usually a physician from a traditional specialty who has added biologic or cell based therapies to their practice. Most common backgrounds include orthopedics, sports medicine, physical medicine and rehabilitation, pain management, and sometimes dermatology or plastic surgery. A smaller group comes from hematology, oncology, or immunology, especially in academic centers working with bone marrow transplants or gene therapies. There is no single standardized residency called “regenerative medicine.” Instead, doctors complete a conventional specialty, then pursue fellowships, courses, or industry sponsored training. That flexibility is a strength, but it is also one of the disadvantages from a patient’s perspective: the quality of training varies widely. Some physicians work in major academic hospitals running controlled clinical trials and offering only treatments backed by early but solid evidence. Others run private clinics that advertise stem cells for nearly every condition imaginable, based on very thin data. When you search “What is a regenerative medicine doctor,” you will find everyone from board certified surgeons to non physician providers using that label. That lack of clear definition should already hint at one of the biggest problems in this field: inconsistency. The biggest problem with regenerative medicine: evidence versus expectations If I had to answer in one sentence what is the biggest problem with regenerative medicine, it would be this: the hype is well ahead of the proof. Many regenerative techniques are still experimental or have only been tested in small, highly selected patient groups. Yet they are often marketed as if they were proven cures for broad categories of disease. Patients naturally ask, “What is the success rate of regenerative medicine?” A responsible answer has to sound like this: it depends entirely on which treatment, for which condition, in which patient, and how you define success. For example: Platelet rich plasma (PRP) for mild to moderate knee osteoarthritis has some encouraging data. A portion of patients see meaningful pain relief for 6 to 12 months, sometimes longer, but it rarely regrows cartilage or “reverses” arthritis. Bone marrow derived cell injections for chronic tendon problems have mixed results. Some patients do very well, others notice little change compared with structured physical therapy. Spinal “stem cell” injections for back pain remain poorly studied and can be risky. Yet they are heavily advertised. The disadvantage is not that these therapies never work. Some patients genuinely improve. The problem is that many clinics quote impressive success rates that are not backed by rigorous, independent trials. They may count any patient who feels “somewhat better” for a few weeks as a success, and they often ignore those who see no benefit or get worse. For patients, this mismatch between expectation and reality creates several risks: financial risk, lost time on effective treatments, and emotional fallout when the “miracle” does not materialize. Cost, income, and the uncomfortable money questions The financial side is one of the most concrete disadvantages of regenerative medicine. Most regenerative procedures in orthopedics, sports medicine, aesthetics, and general pain management are not fully covered by insurance. So people ask two linked questions: “What is the average cost of regenerative medicine?” and “Will insurance pay for regenerative medicine?” Across many private clinics in North America and Europe, you will often see ranges like these: PRP injections: roughly 500 to 2,000 USD per session, sometimes more in large metropolitan areas. Bone marrow derived or adipose derived cell injections: commonly 3,000 to 8,000 USD for a single joint or region. Packages for multiple joints can climb into five figures. More complex biologic or combination protocols promoted by branded clinics can exceed 10,000 USD. Some insurance plans will cover elements connected to the procedure, such as imaging or initial consultations, but deny coverage for the biologic injection itself. A few larger health systems have started partial coverage for specific techniques in narrow indications, but that is the exception, not the norm. When patients ask, “Will insurance pay for regenerative medicine?” the honest general answer remains: often no, or only partially, and you should verify in detail before committing. A practical example: many people ask variations of “Does insurance cover Kinetix?” Kinetix is a brand name used by some providers and clinics for regenerative or biologic injections. Coverage is dependent on the underlying CPT codes and how the insurer classifies the treatment. In most cases, if the treatment is marketed as a regenerative add on and not part of a standard, guideline supported procedure, the patient will be responsible for payment. The only safe approach is to obtain written preauthorization or clear documentation from the insurer. How the economics shape practice Patients also wonder how much do regenerative medicine doctors make and how this dynamic may influence recommendations. There is no uniform salary, since “regenerative medicine doctor” is not a distinct specialty. Income tracks more closely with the underlying field and practice model. For context, in the United States: The highest paid doctor specialty categories are usually orthopedics, plastic surgery, cardiology, and some surgical subspecialties. Their average annual compensation can exceed 600,000 USD, sometimes far more in private practice. The lowest paying doctor specialty categories are often pediatrics, family medicine, and some internal medicine subspecialties, with averages in the 200,000 to 280,000 USD range. A sports medicine or orthopedic physician who builds a cash based regenerative medicine practice can significantly increase income, especially when performing high ticket injections that insurers do not regulate. That does not mean their recommendations are automatically biased, but the financial incentive is real. For patients, this is a disadvantage of the current system: the market rewards offering more procedures, even in gray evidence zones. You have to rely heavily on the ethics of the individual physician and your own due diligence. Pain, discomfort, and downtime: is regenerative medicine painful? Pain is another under discussed downside. Marketing often emphasizes that these treatments are minimally invasive. That is true compared with major surgery, but some procedures are far from pleasant. Relatively low discomfort procedures include superficial PRP injections for some soft tissue conditions. These can sting but are generally well tolerated. Local anesthetic may reduce the initial pain, although anesthetic can sometimes interfere with platelet activity, so protocols vary. More involved procedures can be quite uncomfortable. Bone marrow aspiration for cell based injections typically involves inserting a needle into the pelvic bone to withdraw marrow. Even with local anesthesia and sedation, many patients describe a deep ache during and after the procedure that can last several days. Joint injections into knees or shoulders are usually manageable, but spine or hip injections, or injections into small joints in the hand or foot, can be significantly more painful. Some patients experience a pain flare in the treated area for a week or longer before any potential benefit appears. The short answer to “Is regenerative medicine painful?” is that it often involves some degree of pain or soreness, and in certain procedures, that discomfort is non trivial. Patients who already struggle with chronic pain or anxiety need realistic preparation for that experience. Not everyone is a good candidate Despite how it is advertised, regenerative medicine is not appropriate for every diagnosis or every person. When patients ask, “Who is a good candidate for regenerative medicine?” I tend to look at a cluster of factors. A reasonably good candidate often has: A localized, structurally defined problem, such as a partial tendon tear, focal cartilage defect, or mild to moderate osteoarthritis, rather than diffuse, poorly defined pain. Tried appropriate conservative therapies such as physical therapy, activity modification, weight optimization, and guideline supported medications without adequate relief. Medical stability, without uncontrolled diabetes, severe cardiovascular disease, or active cancer, which could complicate invasive procedures or healing. Realistic expectations about potential benefit, partial improvement, and the possibility of no effect. The disadvantage is that many clinics do not screen carefully. I have seen advertisements offering stem cell injections for advanced, bone on bone arthritis where joint replacement would be a more predictable option, or for neurodegenerative diseases where there is almost no credible human data. For patients in those scenarios, spending thousands on regenerative treatments can delay more appropriate care and leave them physically and financially worse off. Safety, regulation, and the problem of “stem cell” branding Another major downside relates to safety and oversight. “Stem cell” has become a marketing term rather than a precise scientific description. In regulated settings, such as bone marrow transplantation for blood cancers, cell therapies follow strict manufacturing and testing standards. In many commercial clinics, especially outside formal hospital systems, the products may be far less controlled. Documented complications from unregulated or poorly regulated regenerative procedures include infections, tissue damage, unintentional growths or masses, and severe inflammatory reactions. A handful of cases have involved blindness after injections of biologic material around the eye in aesthetic clinics. This is not to say all private regenerative clinics are unsafe, but the variability is high. The disadvantage for patients is that it is hard to distinguish rigorous, ethically run practices from those that prioritize profit. Some people ask, “What country is best for stem cell treatment?” They have heard, for example, that Joe Rogan went to Panama for umbilical cord derived stem cell treatment and felt dramatically better afterward. That story has fueled a wave of interest in Panama, Mexico, and other destinations. The uncomfortable reality is that more permissive countries can offer treatments that are not allowed at home, but they also often have less regulatory oversight. A country can have excellent individual clinics and simultaneously harbor dubious operators. From a safety standpoint, there is no globally agreed “best” country. The safest programs usually combine three features: clear regulatory standards, transparent clinical trial data, and alignment with mainstream academic medicine rather than operating entirely outside it. At present, that often means large centers in the United States, parts of Europe, Japan, and a few carefully vetted institutions in Latin America or Asia, not generic medical tourism hubs. Travel itself adds another disadvantage: long flights after invasive procedures can raise the risk of blood clots, and if complications arise once you are back home, local physicians may be unfamiliar with what was done. The science of regeneration versus the marketing of miracles Patients often ask conceptual questions like, “What are the 4 types of regeneration?” Textbooks use several frameworks, but in a practical clinical sense, you can think of four broad categories of regenerative strategy. A commonly used medical framework includes: Cellular therapies, such as stem cell and progenitor cell injections, or bone marrow derived products. Tissue engineering, which combines cells with scaffolds to build new tissue structures, as in some cartilage repair techniques. Biomaterials and scaffolds without viable cells, designed to support the body’s own healing processes. Gene based therapies that aim to modify or introduce genes to promote repair or correct defects. Each category faces its own technical hurdles. For instance, keeping cells viable and functionally potent from harvest to injection is far from trivial. Engineering tissue that integrates properly with the host without causing immune rejection is equally complex. The marketing materials simplify these problems into sound bites. That gap between the underlying science and the public messaging is itself a disadvantage: patients make life changing decisions based on half explained biology. Questions about fasting show the same pattern. A popular claim floating around is that fasting for 72 hours regenerates cells and rejuvenates the immune system. There are animal studies suggesting prolonged fasting can influence hematopoietic stem cells and immune cell populations. Early human research hints at shifts in certain markers, but we do not have solid evidence that a 72 hour fast repairs organs or reverses chronic disease in people. For most patients, especially those with diabetes, cardiovascular disease, or on Regenerative Medicine Doctor Scottsdale multiple medications, a 72 hour fast carries real risks: hypoglycemia, electrolyte disturbances, fainting, and exacerbation of underlying conditions. It is not a clinically validated regenerative treatment. As with so much else in this field, the promise has outrun the current data. Emotional and psychological downsides Regenerative medicine often reaches people who are already emotionally exhausted by pain or chronic illness. That creates vulnerability. The cycle usually looks like this. A patient tries conventional therapies, fails to improve, and feels dismissed by the system. They discover a clinic that offers hope in precise, confident language. They commit significant savings, perhaps borrowing money. If the treatment helps, wonderful. But if it does not, the disappointment cuts deep. I have spoken with patients who felt ashamed for “falling for it,” even when they made a thoughtful, informed decision with the information they had. Others developed mistrust of all physicians, assuming that every recommendation was financially driven. The disadvantage here is subtle: regenerative medicine can either rebuild trust in medicine when used carefully, or further erode it when oversold. Practical red flags and how to protect yourself Given these disadvantages, some patients still decide that a carefully chosen regenerative procedure is worth a try. That can be reasonable. The key is to approach it as you would any major investment: with structured skepticism and specific questions. Here is one concise checklist of warning signs that should make you pause before proceeding: The clinic treats a very long list of unrelated conditions with the same generic “stem cell” or biologic injection. They quote extremely high success rates without sharing published data or explaining how they define success. Payment is demanded up front, with pressure tactics or limited time “special offers.” There is no discussion of alternative, standard treatments or where your case falls on the spectrum of severity. The provider becomes vague or defensive when you ask about complications, regulatory status, or long term outcomes. If you notice several of these, it is wise to seek a second opinion from a physician who does not sell regenerative treatments, such as an academic specialist. Before saying yes to any procedure, it also helps to ask the clinic targeted questions. A brief starting set might include: Exactly what product or cells will you use, and how are they processed? How many patients like me have you treated, and what outcomes have you tracked? What will my realistic best case, average case, and worst case scenarios look like? How many procedures might I need, and what is the total cost including follow up? Who manages complications if something goes wrong after I return home? Clinics that welcome this kind of questioning and provide clear, non evasive answers are not automatically perfect, but they are usually safer partners than those that bristle at scrutiny. Where regenerative medicine stands, and why its disadvantages matter Regenerative medicine will almost certainly be part of the future of healthcare. Bone marrow transplantation already is. Cartilage repair techniques have matured steadily. Some gene therapies have become approved treatments for specific rare diseases. Yet right now, for many of the conditions that fill glossy brochures and celebrity podcasts, regenerative medicine still sits in a gray zone between promising science and commercial opportunity. The main disadvantages span several layers: uneven evidence, high out of pocket cost, variable training and oversight, genuine pain and risk, and the emotional cost of hope that may not be fulfilled. Understanding those trade offs does not mean turning your back on the field. It means walking into it with your eyes open, asking better questions, and refusing to let marketing replace medicine. Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

I still remember the week Joe Rogan’s stem cell story started circulating in patient conversations. Within a few days, I had three different people in clinic mention “what Joe did in Panama” as if it were a new household treatment. For a field that has been grinding along in the trenches for years, that kind of pop culture exposure is a double edged sword. It brings hope and attention, but it can also distort expectations. As a regenerative medicine physician, I think it helps to walk carefully through what actually happened, what it means for a typical patient, and where the science really stands. Where did Joe Rogan get his stem cell treatment? Rogan has repeatedly described traveling to Panama City, Panama, to a facility known as the Stem Cell Institute. The clinic has been associated in public reporting and in his own discussions with Dr. Neil Riordan, who has long promoted umbilical cord derived mesenchymal stem cell infusions for a wide range of conditions. According to Rogan’s own account, he received high dose intravenous infusions of allogeneic (donor derived) stem cells, along with targeted injections to problem joints. He has said that his joint pain, especially in his shoulders and knees, improved dramatically in the weeks after treatment. Several details here are worth teasing apart. First, this is not the same thing that a typical orthopedic or sports medicine doctor in the United States offers. In the U.S., most legitimate regenerative treatments are autologous. That means we use your own cells and tissues: platelet rich plasma (PRP), bone marrow aspirate concentrate, or microfragmented fat. These are regulated as procedures, not as mass manufactured products. Second, Rogan’s treatment used expanded umbilical cord derived cells from donors. That type of treatment is restricted in the U.S., largely because the FDA classifies expanded stem cell products as biological drugs. To market them broadly, a company needs traditional drug level approval, including large clinical trials. In Panama, the regulatory framework is different, which allows clinics like the Stem Cell Institute to offer expanded cell infusions sooner, with far less published high quality data behind them. Third, Rogan is a single, self reported case. His experience is interesting and his improvement might be real, but it cannot tell you what the average benefit, risk, or cost effectiveness looks like for you. What is a regenerative medicine doctor? Patients use the term “stem cell doctor” loosely, but the more accurate phrase is “regenerative medicine doctor.” At its core, this is a physician who uses biologic therapies that aim to repair or regenerate damaged tissue instead of simply reducing symptoms. In real clinical practice, that typically means a doctor trained in one of a few home specialties - physical medicine and rehabilitation, sports medicine, orthopedics, pain medicine, sometimes rheumatology or interventional radiology - who then adds focused training in regenerative procedures. That training may be fellowships, courses, or years of supervised practice. In my own clinic, a normal week might include: Autologous procedures, like PRP injections for chronic tendinopathy or early arthritis, bone marrow cell concentrates for focal cartilage defects, or fat derived cell preparations for joint degeneration. Biologic adjuncts, such as prolotherapy for ligament laxity or percutaneous tenotomy to stimulate tendon healing. Noninvasive supports, including loading programs, physical therapy, bracing, and sometimes medications, because regenerative medicine works best when integrated into a full plan, not delivered as a magic bullet. Patients sometimes imagine a regenerative medicine doctor as a lab scientist in a white coat holding glowing test tubes. In reality, most of us spend our days in exam rooms and procedure suites, ultrasound probe in one hand and a very practical awareness of anatomy, biomechanics, and patient goals in the other. Why Panama, and why are people flying out of the U.S.? Rogan is far from the only American who has flown abroad for stem cell treatment. The main reasons usually fall into four categories: regulatory limits, cost, dose, and marketing. Regulation comes first. The FDA allows “minimally manipulated” autologous products for homologous use. Translated, that means you can concentrate a patient’s own blood, marrow, or fat, as long as you do not fundamentally alter the cells or repurpose the tissue far from its original function. Expanded, culture grown stem cells, or off the shelf donor products, typically do not fit that rule and are treated like drugs. In the U.S., such products are almost entirely restricted to clinical trials. Countries like Panama, Mexico, parts of the Caribbean, and some European and Asian nations have looser frameworks. They allow clinics to culture cells, bank them, and give high dose repeated infusions without the same drug approval pathway. That gives patients access, but with less rigorous proof. Cost then enters the equation. Ironically, a full “Rogan style” protocol in Panama is not cheap. Package prices of 15,000 to 40,000 USD are commonly cited by patients I see who have shopped around. What you often avoid, however, is the drawn out, insurance driven process of prior authorizations and denials, because you simply pay cash. Dose matters too. Clinics abroad frequently tout very high cell counts - “hundreds of millions” of cells in a single visit. Sounds impressive, but the evidence that more automatically equals better is still lacking in most conditions. Finally, the marketing is aggressive. Offshore clinics know that U.S. Patients are frustrated with the slow pace of regulation and the pain of chronic conditions. When you pair that with high profile testimonials from celebrities or athletes, it is not surprising people start asking if they should follow. What is the biggest problem with regenerative medicine right now? From a physician’s perspective, the biggest problem is the mismatch between hype and evidence. The biology is genuinely promising. You can look at early data in knee osteoarthritis, tendon injuries, and some autoimmune and neurologic diseases and see real signals. But those signals are not yet uniform, large, or long term for many uses. Several practical problems grow from that core issue. Clinical heterogeneity makes it hard to know what you are actually getting. “Stem cell therapy” can mean anything from a carefully prepared bone marrow concentrate injected under ultrasound guidance into a focal lesion, to a for profit clinic in a strip mall giving you a vial of amniotic fluid with very few, if any, live stem cells. Both might cost several thousand dollars, but the underlying product and technique differ wildly. Regulatory gaps allow some bad actors to flourish. In the U.S., the FDA has started cracking down on the worst offenders, including clinics that caused serious harm with unproven injections into eyes or spinal spaces. Abroad, enforcement is often looser. Data scarcity remains a chronic issue. A few conditions have reasonably good evidence for certain regenerative approaches. Mild to moderate knee osteoarthritis with PRP, specific tendon injuries, and some spinal conditions have randomized trials and meta analyses that support careful use. Many other indications, including systemic autoimmune diseases, neurodegenerative disorders, and anti aging uses, rely primarily on early phase trials, registries, or anecdote. Patient expectations are understandably high. When someone hears “regeneration,” they often picture a joint restoring itself to teenage cartilage quality. In practice, most of what we see is improvement, not full reversal. Pain can drop by 30 to 70 percent. Function improves. MRI changes are subtle, if present at all. A therapy can be helpful and worthwhile even if it does not literally grow brand new tissue on command. What are the 4 types of regeneration people talk about? Biologists use the word “regeneration” in a narrower sense than marketers. When patients and clinicians talk about regenerative medicine, we are often actually referring to four overlapping ideas. Tissue repair focuses on improving the body’s normal healing response, for example using PRP to deliver concentrated growth factors to a tendon that keeps re tearing. Here you are not creating new organs, just nudging a stuck process forward. Cellular replacement, which is closer to what people imagine from stem cells. In theory, transplanted or mobilized stem cells help replace damaged cells in cartilage, muscle, or even brain and spinal cord. In practice, most injected stem cells appear to act more as “drug factories,” secreting signals that influence nearby cells, rather than directly turning into new tissue at large scale. Immune modulation, especially with mesenchymal stem cells. There is evidence that certain cell therapies can dampen harmful immune responses and shift inflammatory profiles. That is why you see stem cells studied in conditions like graft versus host disease, Crohn’s disease, and multiple sclerosis. Structural scaffolding, which is common in orthopedics and dentistry. Here, regenerative medicine uses biomaterials, sometimes seeded with cells, to provide a framework where the body can rebuild tissue, such as bone defects after trauma or tumor removal. The treatments at the clinic Rogan visited fall mostly in the cellular replacement and immune modulation categories, though again, the actual degree of replacement versus signaling is still being teased out in lab and clinical work. Is regenerative medicine painful? For most musculoskeletal procedures, the actual experience is more about brief discomfort than true pain, but it varies with the technique and with individual tolerance. PRP injections into a joint or tendon feel similar to a steroid shot, though sometimes more achy afterward. Bone marrow aspiration from the back of the pelvis has sharp pain during the numbing and pressure during the draw. Many patients describe it as uncomfortable for a few minutes, manageable with local anesthetic and sometimes light sedation. High dose intravenous stem cell infusions, like those done in Panama, are usually less painful in the immediate sense. They feel like a long IV session. Some patients report transient flu like symptoms: fatigue, chills, or low grade fever in the day or two afterward, which may relate to immune activation. In my practice, I tell people that if a procedure is intolerable without heavy anesthesia, something about the technique needs to be reconsidered. Careful local anesthesia, ultrasound guidance to avoid unnecessary tissue trauma, and clear expectations go a long way. What is the success rate of regenerative medicine? There is no single number, because “regenerative medicine” is an umbrella, not a single therapy. Success also depends on how you define it: complete cure, meaningful symptom reduction, return to sport, delay of surgery, or simply safety. For context, in mild to moderate knee osteoarthritis, higher quality trials of PRP find that somewhere between about 50 and 70 percent of patients report clinically meaningful pain reduction at 6 to 12 months, often beating hyaluronic acid injections and approaching or sometimes exceeding corticosteroid in durability. That does not mean everyone avoids knee replacement, but many delay it. For chronic tennis elbow, PRP and related interventions show success rates in that same general range, often 60 to 80 percent of patients reporting significant improvement at one year compared with traditional care. Stem cell based approaches are more variable. Some early studies of bone marrow cell injections for focal cartilage defects show improvement in pain and function in most patients, but with smaller sample sizes and shorter follow up than we would like. For systemic conditions such as autoimmune disease or neurologic injury, the evidence is much thinner, and success rates are harder to quantify, especially outside trials. Celebrity stories, like Rogan’s, often represent the favorable end of that spectrum. The less dramatic outcomes are less likely to be discussed on podcasts. Does fasting for 72 hours regenerate cells in the same way? Fasting has become another popular topic among people chasing regeneration. The short answer is that prolonged fasting, including 48 to 72 hour windows, can activate processes such as autophagy and may influence stem cell activity, particularly in immune cells. Some human studies show changes in white blood cell counts and markers of metabolic health after multi day fasts. That said, fasting for 72 hours does not “regenerate cells” in the same sense that an injected stem cell preparation does. You are not adding new cells from outside. You are changing the environment the existing cells live in, pushing some to recycle damaged components and perhaps stimulating stem cell niches to repopulate immune cells after refeeding. I tell curious patients that thoughtful fasting, if medically safe for them, can be one tool among many to support cellular health. It does not replace targeted regenerative procedures for structural problems like advanced joint arthritis or tendon tears. Who is a good candidate for regenerative medicine? The patients who tend to do best share several characteristics, both medical and behavioral. First, the underlying condition is structurally amenable. A knee with moderate cartilage thinning, some meniscal fraying, and pain with activity is a very different target from a knee with no cartilage at all and bone grinding on bone. Regenerative injections often shine in that mild to moderate window, or in focal problems like specific tendon tears, more than in end stage destruction. Second, comorbidities are reasonably controlled. Diabetes, smoking, uncontrolled inflammatory disease, obesity, and certain medications can all blunt healing. I do treat patients with these issues, but I counsel them that success rates may be lower and that optimizing those factors first enhances any biologic procedure. Third, expectations are realistic. A good candidate understands that improvement might mean less pain and more function, not a complete rewind to age 20. They are willing to participate in rehab, modify training loads, and give the therapy months, not days, to show effect. Fourth, financial risk tolerance matters. Since many regenerative treatments are not covered by insurance, a patient needs to be in a position where spending, for example, 2,000 to 8,000 dollars on a procedure is a considered investment, not a desperate last gamble that will create financial harm if the outcome is modest. Finally, follow through is key. The best biologic injection can still fail if the patient ignores post procedure instructions, resumes heavy loading too early, or neglects the strengthening and mobility work that allows new tissue and improved signaling to translate into durable function. Checklist style, the core elements are: a structurally appropriate target, manageable medical risk, aligned expectations, financial clarity, and willingness to engage in rehab and lifestyle work. Will insurance pay for regenerative medicine, and does insurance cover Kinetix? This is one of the most practical questions I hear, and the answer is usually not what patients hope. In the United States, most commercial insurance plans and Medicare classify common regenerative injections such as PRP, bone marrow aspirate concentrate, and many branded protocols as experimental or investigational. That means they do not pay for the biologic portion of the treatment. They may, however, cover related services such as the office visit, imaging, physical therapy, or bracing. Some plans have started to cover PRP for very specific indications, such as certain tendinopathies, but this remains the exception, not the rule. As for Kinetix, which is a branded regenerative offering some clinics market as a package of biologic injections and rehabilitation protocols, the situation is similar. In my experience, Regenerative Medicine Doctor Scottsdale and based on payer policy documents I have reviewed, insurers almost never cover the proprietary, regenerative part of those programs. They might cover associated physical therapy or imaging if billed separately with standard codes, but the core “Kinetix” procedure itself is treated as self pay. Given how fast policies change, I always advise patients to call their insurance directly, ask about coverage for the specific CPT codes the clinic plans to use, and get any verbal pre authorizations noted in the insurer’s system. Surprises around bills tend to sour even good clinical outcomes. What is the average cost of regenerative medicine? Costs vary widely by region, physician expertise, and the specific procedure, but a few ranges are typical in the U.S. PRP injections usually range from about 500 to 1,500 dollars per treatment, depending on the complexity of the preparation and whether ultrasound guidance is used. Many protocols involve one to three sessions per body part. Bone marrow aspirate concentrate treatments tend to fall in the 2,500 to 6,000 dollar range per major joint or region, reflecting both the time and equipment involved in the aspiration and processing. Fat derived cell preparations often land in a similar or slightly higher bracket, 3,000 to 7,000 dollars, partly due to the need for liposuction style harvesting and more involved processing systems. Travel abroad for high dose donor derived stem cells, like Rogan’s trip to Panama, stretches that range. It is common to hear patient reported quotes around 15,000 to 40,000 dollars for multi day infusion packages, not including flights, lodging, and lost work time. Compared to surgery, these numbers can still be competitive, but because so much is out of pocket, the psychological impact feels different. For many patients, the key decision point is whether the potential benefit and the chance to delay or avoid surgery are worth a several thousand dollar investment that may or may not succeed. What are the disadvantages of regenerative medicine? It is easy to focus on potential upside and celebrity testimonials. In clinic, I spend just as much time on drawbacks, because those shape whether a treatment fits a particular person’s situation. The main disadvantages usually fall into five buckets. First, cost and lack of insurance coverage. Most regenerative procedures remain out of pocket. That alone makes them inaccessible to many. Second, imperfect and uneven evidence. We have good data for some indications, modest data for others, and almost no data for a long tail of conditions that Integrated Spine, Pain and Wellness Regenerative Medicine Doctor Scottsdale aggressive marketers still advertise. Third, procedural risks, while generally low, are real. Infection, bleeding, flare of inflammation, nerve irritation, and, in rare cases, serious complications such as clots or neurologic injury can occur, especially when injections are done into high risk areas like the spine by undertrained providers. Fourth, time and opportunity costs. A patient who spends money and months invested in a regenerative program that does not help may delay other treatments, such as surgery or disease modifying medications, that would have been more appropriate earlier. Fifth, regulatory and quality issues, particularly with certain amniotic, umbilical, or “stem cell” products sold in the U.S. And abroad that contain few or no viable cells. Patients are sometimes paying for the idea of stem cells more than an actual, well characterized biologic product. When regener­ative medicine is offered transparently, within the bounds of evidence, and by experienced clinicians, those disadvantages can be managed and weighed. When it is sold as a guaranteed fix, they are often ignored. How much do regenerative medicine doctors make, and how does that compare? Patients sometimes ask this bluntly, especially when they are considering a several thousand dollar cash procedure. They want to know if their doctor is incentivized to recommend more treatments than medically necessary. There is no single salary for a “regenerative medicine doctor,” because it is not a primary specialty. Income depends heavily on the underlying field and practice model. A physiatrist or sports medicine physician who integrates regenerative procedures into a larger insurance based practice might earn in the range of 250,000 to 450,000 dollars annually. An orthopedic surgeon who runs a partly concierge, procedure focused clinic may earn more. In broader surveys, the highest paid doctor specialty in the U.S. Typically includes procedural fields such as orthopedics, plastic surgery, cardiology, and some neurosurgical disciplines, with average incomes in the 500,000 to 800,000 dollar range, sometimes higher in private practice. The lowest paying doctor specialty is often primary care pediatrics, family medicine, or public health focused fields, which may cluster between about 200,000 and 275,000 dollars, depending on region and setting. Regenerative medicine sits across that spectrum. It can be a modest adjunct or a significant profit center, which is precisely why transparency about indications, pricing, realistic outcomes, and alternatives is so important. Patients should feel free to ask doctors how they are paid, whether they have ownership in particular labs or products, and what less expensive options exist. What country is best for stem cell treatment? People often phrase this as if there is a global ranking: Panama first, Germany second, the U.S. Third, and so on. Reality is more nuanced. The U.S. Has strong regulation and some of the best clinical trial infrastructure in the world. For indications where evidence based autologous procedures are appropriate, you can receive high quality care without leaving the country. For experimental donor derived therapies, clinical trials here are carefully monitored, but access is limited and often restricted to specific diseases. Panama, where Rogan went, along with Mexico and several Caribbean destinations, offers broader access to high dose, culture expanded stem cells, especially from umbilical cord tissue. The upside is availability and the ability to treat multiple conditions under one protocol. The downside is that many of these uses are not backed by large, controlled trials, and regulatory oversight is less robust. Some European countries, like Germany and the United Kingdom, occupy a middle ground, with centers that offer sophisticated autologous and some allogeneic therapies within more controlled frameworks. Japan has also built a regulated pathway for certain regenerative products. The “best” country depends more on your diagnosis, risk tolerance, and ability to participate in trials than on national borders. For many orthopedic and sports problems, excellent regenerative care can be obtained domestically in the U.S., Europe, or other developed healthcare systems. For systemic, high dose stem cell infusions similar to Rogan’s, the only legal options often involve travel, with all the attendant trade offs. Regenerative medicine sits at an interesting crossroads. The story of a high profile patient flying to Panama for stem cells captures the imagination, but it is not a template for everyone. The field contains real promise, genuine progress, and a fair amount of noise. A careful conversation with an experienced regenerative doctor, grounded in your specific anatomy, goals, and constraints, will take you much further than any single celebrity testimonial, Rogan’s included.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823